v3.26.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2025
Pfizer Savings Plan  
EBP, Investment, Fair Value and NAV [Line Items]  
Schedule of Plan Investments at Fair Value
The following tables set forth by level, within the fair value hierarchy, the Plan’s investments at fair value:
Fair Value as of December 31, 2025
(THOUSANDS OF DOLLARS)
Level 1
Level 2
Total
Pfizer Inc. common stock
$938,916 $— $938,916 
Common/collective trust funds
— 18,660,013 18,660,013 
Mutual funds
566,228 — 566,228 
Self-directed brokerage account
487,501 — 487,501 
Separate account:
Common stock
1,761,828 — 1,761,828 
Common/collective trust funds
— 38,734 38,734 
Other
57,391 — 57,391 
   Total
$3,811,864 $18,698,747 $22,510,611 
Fair Value as of December 31, 2024
(THOUSANDS OF DOLLARS)
Level 1
Level 2
Total
Pfizer Inc. common stock
$1,058,778 $— $1,058,778 
Common/collective trust funds
— 16,252,996 16,252,996 
Mutual funds
838,470 — 838,470 
Self-directed brokerage account
408,798 — 408,798 
Separate account:
Common stock
1,686,294 — 1,686,294 
Common/collective trust funds
— 24,669 24,669 
Other31,839 — 31,839 
   Total
$4,024,179 $16,277,664 $20,301,844